Next Article in Journal
Tracking Trends in Emissions of Developmental Toxicants and Potential Associations with Congenital Heart Disease in Alberta, Canada
Previous Article in Journal
Industrial Developmental Toxicants and Congenital Heart Disease in Urban and Rural Alberta, Canada
Previous Article in Special Issue
The ADP-Ribosyl-Transferases Diphtheria Toxin-Like (ARTDs) Family: An Overview
Article Menu

Export Article

Open AccessArticle
Challenges 2018, 9(2), 27; https://doi.org/10.3390/challe9020027

Measurement of Poly(ADP-ribose) Level with Enhanced Slot Blot Assay with Crosslinking

1
Genome Stability Research Division, Lab of Collaborative Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
2
Division of Materials Science & Chemical Engineering, Graduate School of Engineering, Yokohama National University, 79-5, Tokiwadai, Hodogaya-ku, Yokohama 240-8501, Japan
3
Division of Cell Signaling, Lab of Collaborative Research, National Cancer Center Research Institute, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
4
Department of Frontier Life Sciences, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8588, Japan
5
Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo 104-0045, Japan
6
Department of Pharmacology, Faculty of Dentistry, Osaka Dental University, 8-1, Kuzuhahanazono-cho, Hirakata, Osaka 573-1121, Japan
Current address: Oncologic Pathology Graduate School of Medicine, Mie University, 2-174 Edobashi, Tsu 514-8507, Japan
*
Author to whom correspondence should be addressed.
Received: 29 March 2018 / Revised: 22 June 2018 / Accepted: 26 June 2018 / Published: 2 July 2018
View Full-Text   |   Download PDF [1466 KB, uploaded 2 July 2018]   |  

Abstract

Poly(ADP-ribose) (PAR) formation is catalyzed by poly(ADP-ribose) polymerase (PARP) family proteins in nuclei as well as in cytosols. The anti-PAR antibodies that specifically detect PAR are useful for the quantitative measurement of PAR in cells, in tissue, and in the body. In clinical trials of PARP inhibitors, a pharmacodynamic (PD) assay for the measurement of PARP activity inhibition in peripheral blood mononuclear cells (PBMCs) with dot-blot assay or an ELISA assay using anti-PAR antibodies have been used. In these assays, ex vivo PARP activity and its inhibition assay have been used. For a PD assay to assess the efficacy of the treatment, the measurement of PARP activity inhibition in tumor tissues/cells has been recommended. A dot or slot blot assay may also be suitable for the measurement of such crude tissue samples. Here, we investigate the optimum conditions for a dot/slot blot assay of an ex vivo PARP activity assay by utilizing physical and chemical crosslinking methods. Using 10H monoclonal antibody to PAR, we show that use of a nylon membrane and UV crosslink at 254 nm can stably enhance the detection level of PAR. However, the limitation of this assay is that the size of PAR detectable using the 10H antibody must be around 20 ADP-ribose residues, since the antibody cannot bind PAR of lower size. View Full-Text
Keywords: poly(ADP-ribose); PARP inhibitor; pharmacodynamic assay; UV crosslink poly(ADP-ribose); PARP inhibitor; pharmacodynamic assay; UV crosslink
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Kudo, Y.; Sasaki, Y.; Onodera, T.; Hashimoto, J.; Nozaki, T.; Tamura, K.; Watanabe, M.; Masutani, M. Measurement of Poly(ADP-ribose) Level with Enhanced Slot Blot Assay with Crosslinking. Challenges 2018, 9, 27.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Challenges EISSN 2078-1547 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top